Results 21 to 30 of about 319,430 (262)

Endotoxin detection in end-stage kidney disease [PDF]

Journal of Clinical Pathology, 2014
Aims Endotoxin detection assays are not validated for use in end-stage kidney disease (ESKD). We investigated the accuracy and precision of the kinetic turbidimetric Limulus amoebocyte lysate (LAL) assay to detect endotoxin in plasma from patients with ESKD.
Jonathan, Wong, Hassan, Jeraj, Enric, Vilar, Adie, Viljoen, Ken, Farrington   +4 more
openaire   +2 more sources

How to increase dialysis adequacy; A randomized clinical trial [PDF]

Journal of Nephropathology, 2020
Introduction: Studies have shown when hemodialysis treatment is sufficiently effective, complications of uremic syndrome, additional treatment costs and hospitalization length are reduced.
Afsaneh Dashti, Nahid Shahgholian, Maryam Mafi, Fateme Goudarzi, Seyedehzahra Hoseinigolafshani   +4 more
doaj   +1 more source

Clinical and financial impact of chronic kidney disease in emergency general surgery operations

Surgery Open Science, 2022
Introduction: Chronic kidney disease is frequently encountered in clinical practice and often requires more intricate management strategies. However, its impact on outcomes of patients warranting emergency general surgery has not been well characterized.
Vishal Dobaria, BS, Joseph Hadaya, MD, Shannon Richardson, MS, Cory Lee, DO, Zachary Tran, MD, Arjun Verma, Yas Sanaiha, MD, Peyman Benharash, MD   +7 more
doaj   +1 more source

End of life care in end-stage kidney disease

Indian Journal of Palliative Care, 2021
There is a rise in burden of end-stage renal disease globally and in India. The symptom burden, prognosis, and mortality in chronic kidney disease closely mimics that of cancer. However, the palliative and end of life care needs of these patients are seldom addressed.
Prabhu, Ravindra Attur, Salins, Naveen, Bharathi,, Abraham, Georgi   +3 more
openaire   +3 more sources

Cerebrovascular disease in end-stage kidney disease [PDF]

Renal Replacement Therapy, 2016
Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease and also increases the incidence of cerebrovascular disease. Prevention and management of cerebrovascular disease in patients with CKD, especially end-stage kidney disease (ESKD), are different from those without CKD because of their specific pathophysiology.
Tsuruya, Kazuhiko, Fujisaki, Kiichiro
openaire   +1 more source

Impact of end stage kidney disease on costs and outcomes of Clostridium difficile infection

International Journal of Infectious Diseases, 2017
Objectives: To assess the impact of end stage kidney disease (ESKD) on the outcomes of Clostridium difficile infection (CDI), including complications of infection, length of hospital stay, overall mortality, and healthcare burden.
Abhinav Goyal, Kshitij Chatterjee, Sujani Yadlapati, Janani Rangaswami   +3 more
doaj   +1 more source

Rural Versus Urban Health Service Utilization and Outcomes for Renal Patients in New South Wales: Protocol for a Data Linkage Study

JMIR Research Protocols, 2015
BackgroundKidney disease is a significant burden on health systems globally, with the rising prevalence of end stage kidney disease in Australia mirrored in many other countries. Approximately 25% of the Australian population lives in regional and rural
Kotwal, Sradha, Webster, Angela, Cass, Alan, Gallagher, Martin   +3 more
doaj   +1 more source

Re: Renal Transplantation in Children Weighing <15 kg: Does Concomitant Lower Urinary Tract Dysfunction Influence the Outcome?

Journal of Urological Surgery, 2015
The most beneficial effects of renal transplantation (RTx) are observed in patients younger than 5 years and weighing less than 15 kg. However the subgroup of patients below 15 kg requiring RTx is a very unique group that has never been assessed ...
Ghirardo G, Midrio P, Zucchetta P, Gamba P   +3 more
doaj   +1 more source

Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. [PDF]

PLoS ONE, 2018
BACKGROUND:Proton pump inhibitor use is associated with incident chronic kidney disease, chronic kidney disease progression and end-stage renal disease.
Hee Jeong Lee, Haekyung Lee, Song Hee Oh, Joonbyung Park, Suyeon Park, Jin Seok Jeon, HyunJin Noh, Dong Cheol Han, Soon Hyo Kwon   +8 more
doaj   +1 more source

Ventricular tachycardia in end-stage kidney disease. [PDF]

Proc (Bayl Univ Med Cent)
Mehta AN.
europepmc   +3 more sources